VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RELI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RELIReliance Global Group, Inc.
$0.25$553552
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRELIQuarterly Financials

Reliance Global Group, Inc. (RELI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Reliance Global Group, Inc. (RELI) quarterly income statement — complete revenue, gross profit & net income history

RELI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Revenue2.5M3.09M4.24M3.3M3.44M3.23M4.08M3.32M3.28M3.2M3.94M4.16M2.82M2.85M4.24M2.61M2.58M2.19M2.32M1.95M
Revenue Growth %-27.47%-4.54%3.77%-0.73%5.06%1.17%3.64%-20.16%16.08%12.25%-7%59.12%9.3%29.96%82.28%33.84%53.66%33.42%15.94%12.22%
Medical Costs & Claims4.91M3.55M3.7M2.86M2.61M2.84M3.11M3.3M2.6M2.6M2.84M2.99M2.32M2.3M2.99M2.13M1.85M1.67M1.45M1.42M
Medical Cost Ratio %196.65%115.08%87.32%86.64%75.84%87.88%76.14%99.47%79.37%81.36%72.08%71.78%82.39%80.79%70.5%81.65%71.62%76.18%62.31%72.95%
Gross Profit-2.41M-465.62K536.96K440.42K831.48K391.83K974.23K17.72K675.88K595.57K1.1M1.17M496.8K546.8K1.25M479.73K732.66K521.95K875.71K528.3K
Gross Margin %-96.65%-15.08%12.68%13.36%24.16%12.12%23.86%0.53%20.63%18.64%27.92%28.22%17.61%19.21%29.5%18.35%28.38%23.82%37.69%27.05%
Gross Profit Growth %-390.12%-218.83%-44.88%2385.98%23.02%-34.21%-11.42%-98.49%36.05%8.92%-11.97%144.65%-32.19%4.76%42.68%-9.19%84.63%24.3%23.26%-16.95%
Operating Expenses1.5M1.91M1.94M1.45M1.34M1.54M6.01M9.62M2.11M2.43M2.1M17.01M1.83M2.32M3.65M1.33M1.21M1.63M1.36M1.25M
OpEx / Revenue %60.15%61.76%45.89%43.84%39.04%47.58%147.12%289.61%64.44%76.15%53.43%409%64.92%81.48%86.11%50.77%46.79%74.25%58.55%63.88%
Depreciation & Amortization313.69K346.15K360.6K360.37K421.76K469.79K534.15K647.13K652.84K767.35K653.78K724.45K651.39K694.44K607.53K517.13K387.73K369.37K333.09K322.27K
Combined Ratio %256.8%176.84%133.22%130.48%114.88%135.46%223.25%389.08%143.81%157.52%125.51%480.78%147.31%162.27%156.62%132.42%118.41%150.43%120.87%136.83%
Operating Income-3.91M-2.37M-1.41M-1.01M-511.98K-1.15M-5.03M-9.6M-1.44M-1.84M-1M-15.84M-1.33M-1.77M-2.4M-847.47K-475.21K-1.1M-484.86K-719.29K
Operating Margin %-156.8%-76.84%-33.22%-30.48%-14.88%-35.46%-123.25%-289.08%-43.81%-57.52%-25.51%-380.78%-47.31%-62.27%-56.62%-32.42%-18.41%-50.43%-20.87%-36.83%
Operating Income Growth %-664.43%-106.86%72.03%89.53%64.32%37.62%-400.71%39.38%-7.5%-3.68%58.1%-1768.99%-180.93%-60.48%-394.62%-17.82%56.49%-7.74%39.96%54.39%
EBITDA-3.6M-2.03M-1.05M-644.67K-90.22K-676.79K-4.5M-8.95M-782.22K-1.07M-351.15K-15.11M-683.6K-1.08M-1.79M-330.34K-87.48K-735.42K-151.77K-397.02K
EBITDA Margin %-144.23%-65.63%-24.7%-19.55%-2.62%-20.93%-110.17%-269.59%-23.88%-33.51%-8.91%-363.36%-24.23%-37.88%-42.27%-12.64%-3.39%-33.57%-6.53%-20.33%
Interest Expense246.72K318.99K325.24K378.71K391.12K403.5K410.29K404.87K419.04K422.06K393.3K0282.93K196.66K000000
Non-Operating Income020.1K4.5K14.46K-65.78K-60.68K-95.34K-1.12M-1.72M1.61M-4.27M-14.37M-7.91M-12.63M000000
Pretax Income-1.16M-2.71M-1.74M-1.4M-837.31K-1.49M-5.35M-8.89M-139K-3.87M2.87M-19.49M6.3M10.66M9.34M-18.61M-595.23K-1.28M-613.93K-349.23K
Pretax Margin %-46.34%-87.83%-41%-42.41%-24.33%-46.06%-130.97%-267.62%-4.24%-121.08%72.91%-468.59%223.14%374.41%220.5%-712%-23.06%-58.28%-26.42%-17.88%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.16M-2.71M-1.74M-1.4M-837.31K-1.49M-5.35M-9.03M-139K-1.06M-1.79M-19.49M6.12M10.5M9.34M-18.61M-595.23K-1.28M-613.93K-349.23K
Net Margin %-46.34%-87.83%-41%-42.41%-24.33%-46.06%-130.97%-271.8%-4.24%-33.02%-45.4%-468.59%216.96%368.64%220.5%-712%-23.06%-58.28%-26.42%-17.88%
Net Income Growth %-38.13%-82.01%67.51%84.51%-502.37%-41.14%-198.94%53.69%-102.27%-110.05%-119.15%-4.72%1128.52%921.98%1621.36%-5229.61%51.67%-12.16%37.34%80.17%
EPS (Diluted)-0.20-0.85-66.48-1.39-0.67-1.27-4.55-7.69-0.12-0.901.340.8511.8516.3913.40-27.65-0.82-1.75-1.28-1.25
EPS Growth %70.15%33.07%-1361.1%81.92%-458.33%-41.11%-439.55%-1004.71%-101.01%-105.49%-90%103.07%1545.12%1036.57%1146.88%-2112%81.53%57.32%74.6%86.38%
EPS (Basic)-0.20-0.85-66.48-1.39-0.67-1.27-4.55-7.69-0.12-0.901.340.8511.8918.3617.35-27.65-0.82-1.75-1.28-1.25
Diluted Shares Outstanding5.83M3.2M26.13K1.01M1.25M1.17M1.17M1.17M1.17M1.17M1.17M1.22M1.16M1.4M1.57M673.14K729.63K728.97K502.82K278.91K